ADC Therapeutics Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for ADC Therapeutics stock have an average target of 7.75, with a low estimate of 5.00 and a high estimate of 10. The average target predicts an increase of 105.57% from the current stock price of 3.77.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$5.00	$7.75	$8.00	$10
Change	+32.63%	+105.57%	+112.20%	+165.25%

* Price targets were last updated on Mar 23, 2026.

Analyst Ratings

The average analyst rating for ADC Therapeutics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	2	2	2	2	2	2
Buy	4	4	4	4	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $7 → $8	Strong Buy	Maintains	$7 → $8	+112.20%	Mar 23, 2026
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $8 → $7	Strong Buy	Maintains	$8 → $7	+85.68%	Oct 16, 2025
Michael Schmidt Guggenheim	Guggenheim	Strong Buy Reiterates $10	Strong Buy	Reiterates	$10	+165.25%	Aug 13, 2025
Leonid Timashev RBC Capital	RBC Capital	Buy Maintains $8 → $5	Buy	Maintains	$8 → $5	+32.63%	Jun 20, 2025
Michael Schmidt Guggenheim	Guggenheim	Strong Buy Maintains $7 → $10	Strong Buy	Maintains	$7 → $10	+165.25%	Jun 13, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

79.63M

from 81.36M

-2.13%

from 81.36M

Revenue Next Year

132.57M

from 79.63M

66.49%

from 79.63M

EPS This Year

-0.82

from -1.12

EPS Next Year

-0.65

from -0.82

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	33.92M	209.91M	69.56M	70.84M	81.36M	79.63M	132.57M
Revenue Growth	-	518.89%	-66.86%	1.84%	14.85%	-2.13%	66.49%
EPS	-3.00	-2.01	-2.94	-1.62	-1.12	-0.82	-0.65
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	8	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	92.3M	147.6M
Avg	79.6M	132.6M
Low	69.5M	114.9M

Revenue Growth

Revenue Growth	2026	2027
High	13.5%	85.4%
Avg	-2.1%	66.5%
Low	-14.6%	44.2%

EPS Forecast

EPS	2026	2027
High	-0.64	-0.27
Avg	-0.82	-0.65
Low	-0.89	-0.83

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.